Company news
908 Devices Inc. news in 2024
908 Devices Inc.'s news releases, calls and decks from 2024, newest first.
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
November 11, 2024
908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024
October 21, 2024
908 Devices to Participate in Craig-Hallum Bioprocessing Conference
September 5, 2024
908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook
August 5, 2024
908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference
July 29, 2024
908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024
July 22, 2024
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
June 24, 2024
908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors
June 17, 2024
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
April 29, 2024
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
April 29, 2024
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
April 22, 2024
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
March 11, 2024
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
March 4, 2024
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
February 28, 2024
908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
February 19, 2024
Calls in 2024
Decks in 2024
- Q1 2024 Earnings Presentation
Earnings · 15 slides · Apr 30, 2024